Chard

Chard (Beta vulgaris subsp. vulgaris, Cicla and Flavescens Groups)

1. Identity: Botanical Classification, Names, and Common Forms

Taxonomy and Nomenclature

Chard (Beta vulgaris subsp. vulgaris, Cicla Group and Flavescens Group) is a green leafy vegetable. It belongs to the family Amaranthaceae. All cultivated Beta vulgaris varieties fall into the subspecies Beta vulgaris subsp. vulgaris. The wild ancestor of these cultivated varieties is Beta vulgaris subsp. maritima, commonly known as the sea beet, found throughout the Mediterranean, the Atlantic coast of Europe, the Near East, and India.

Beta vulgaris has four different cultivated forms: the common garden beet (also called beetroot or table beet) grown for its roots; the sugar beet used to produce sugar; mangelwurzel, a fodder crop; and Swiss chard, also known as chard, leaf beet, or silverbeet, grown for its nutrient-rich leaves. Though the generally accepted taxonomic name for Swiss chard is Beta vulgaris subsp. vulgaris, its taxonomic rank has changed many times, and it is also occasionally indicated as Beta vulgaris var. vulgaris or Beta vulgaris var. cicla.

Chard is also called silver beet, perpetual spinach, beet spinach, seakale beet, and leaf beet; because it is the same species as beetroot, these other common names may overlap. Its name comes from the Latin word for "thistle" (carduus). It is thought that Dutch seed merchants of the 19th century added the word "Swiss" to differentiate the plant from French spinach varieties.

Botanical Varieties and Cultivars

Cultivars of chard include green forms, such as 'Lucullus' and 'Fordhook Giant', as well as red-ribbed forms, such as 'Ruby Chard' and 'Rhubarb Chard'. Its classification within Beta vulgaris highlights its origin from the wild sea beet, a coastal plant native to Europe and North Africa. In the cultivars of the Flavescens Group, or Swiss chard, the leaf stalks are large and often prepared separately from the leaf blade. The colored pigments in petioles (stems) vary by cultivar, producing red, yellow, white, orange, and multicolored "rainbow chard" forms; the colorful varieties called "rainbow chard" have brightly colored stems and red-purple and yellow-orange veins, which are evidence of betalain pigments.

Common Forms and Preparations

The young leaves can be eaten raw in salads, while larger leaves and stalks are commonly sautéed or served in soups. Chard is available fresh, as frozen leaf, and—in supplement or nutraceutical contexts—as dried leaf powder, aqueous extract, or ethanol extract. The plant has been studied as an alternative green leafy vegetable for human consumption as well as a source of concentrated bioactive extracts in pharmacological research.

2. Historical and Traditional Use

Ancient World

Prized for its medicinal properties as much as its culinary versatility, ancestors of chard supposedly grew in the fabled Hanging Gardens of Babylon, flourished in China during the 7th century BC, and were even written about by Aristotle in Ancient Greece. Several sources mention Aristotle giving recognition to red-stalked chard around 350 BCE and that both his Greek colleagues and Roman counterparts revered it for its medicinal prowess. Ancient Greek and Roman populations frequently grew and ate these greens, as they were aware of the many healing properties.

In the Babylonian Talmud, a foundational Jewish text from late antiquity, chard is praised for its health benefits. In tractate Eruvin 29a, it is said that a cooked dish of chard "is good for the heart and good for the eyes, and all the more so for the intestines." In another passage, Berakhot 44b, it states: "Cabbage for food, mangold for medicine."

Medieval and Early Modern Europe

Chard has grown in Britain since at least 1596, when English botanist John Gerard recorded growing it in his famous Herball. In traditional Mediterranean diets, Swiss chard was a staple vegetable, valued for its nutritional value and contribution to overall well-being. In traditional Mediterranean diets, chard was a common ingredient in soups and stews, believed to strengthen the body and promote overall well-being.

Folk Medicine Uses

Swiss chard has been used in folk medicine as a natural decongestant, allergy reliever, constipation reliever, and joint pain reducer—likely because it lowered inflammation. Swiss chard and beetroot have a long history of use in folk medicine. Chard (Beta vulgaris L. var. cicla) has specifically been used as a hypoglycemic agent by diabetic patients in Turkey. It was also considered a nourishing food that could help cleanse the blood and support liver function. These traditional uses are based on anecdotal evidence and cultural practices rather than controlled clinical evidence.

3. Key Constituents and Active Compounds

Overall Phytochemical Profile

A 2020 systematic review identified a total of 192 chemical compounds in Swiss chard categorized into 23 groups. Betalains represented 20% of reported compounds, followed by fats (16%), flavonoids (11%), non-flavonoid phenolics (11%), terpenes and derivatives (8%), carbohydrates (7%), and minerals (6%).

Flavonoids (C-Glycosyl Flavones)

The green beet (Beta vulgaris var. cicla L.) contains apigenin, vitexin, vitexin-2-O-xyloside, and vitexin-2-O-rhamnoside. These phytochemicals show considerable antioxidant activity, as well as anti-inflammatory and antiproliferative activities. Chard contains apigenin flavonoids, namely vitexin, vitexin-2-O-rhamnoside, and vitexin-2-O-xyloside, which show antiproliferative activity on cancer cell lines. The primary phenolic components identified by HPLC-ESI-MS/MS include vitexin-2′′O-rhamnoside, its demethylated form 2′′-xylosylvitexin, isorhamnetin 3-gentiobioside, and rutin. Additional flavonoids include quercetin, kaempferol, rutin, and vitexin. Total flavonoid content has ranged from 28.2 to 276 mg/100 g across different studies, reflecting variation in cultivar, growing conditions, and analytical methods.

Betalains

Betalains have demonstrated an ability to protect human red blood cells from oxidative hemolysis, to scavenge hypochlorous acid produced by neutrophils during the inflammatory response, to protect endothelial cells from the oxidation processes related to inflammatory response, and to inhibit lipid peroxidation of cell membranes in the blood. Betalains also possess anticancer activity by hindering the infiltration capacity of tumoral cells, decreasing cell proliferation, and inducing apoptosis. In the colored petioles of the Flavescens Group in particular, betalains contribute the visible pigmentation.

Carotenoids

Swiss chard is loaded with a diverse range of antioxidants, including beta-carotene, alpha-carotene, lutein, zeaxanthin, and flavonoids such as quercetin and kaempferol. Swiss chard is a fantastic source of carotenoids, providing an impressive 10,578.2 µg of carotenoids per 2-cup serving. Swiss chard contains significant amounts of lutein and zeaxanthin, two carotenoid antioxidants that accumulate in the retina of the eye, acting as natural sunblock and filtering out harmful high-energy blue light waves while protecting the eye from oxidative damage.

Non-Flavonoid Phenolics

Myricitrin, p-coumaric acid, and rosmarinic acid have been characterized in chard leaves. Phytochemical screening of chard has revealed fatty acids (stearic, palmitic, linoleic, oleic, and linolenic acids), phospholipids, glycolipids, polysaccharides, ascorbic acid, folic acid, pectins, saponins, flavonoids (apigenin), phenolic acids, and betalains.

Alpha-Lipoic Acid

Swiss chard contains an antioxidant known as alpha-lipoic acid, which has been shown to lower glucose levels, increase insulin sensitivity, and prevent oxidative stress-induced changes in patients with diabetes.

Vitamins and Minerals

Swiss chard is exceptionally rich in vitamin K, with a single cooked cup (175 g) providing nearly 480% of the daily value, and it contributes meaningful amounts of vitamin A (via carotenoids), vitamin C, and vitamin E; magnesium, potassium, iron, manganese, and copper stand out. One cooked cup can provide around one-third of an adult's magnesium needs and 20% of potassium, both important for blood pressure control and nerve and muscle function. It is also plentiful in B-complex vitamins such as folates, niacin, vitamin B-6 (pyridoxine), thiamin, and pantothenic acid, essential for optimum cellular metabolic functions. Mineral analysis confirmed Swiss chard as a good calcium, magnesium, potassium, and iron source, with significant variation between leaves and stems: leaves are richer in calcium, magnesium, iron, manganese, and zinc, while stems contain higher levels of sodium and potassium.

Oxalic Acid

Swiss chard has a very high oxalate content, one of the highest among edible vegetables; 100 grams of fresh leaves contain 480 mg of oxalates, of which about half is in soluble form. The presence of oxalic acid has important implications for mineral bioavailability and safety, discussed in the safety section below.

Dietary Nitrates

Leafy greens like Swiss chard are naturally nitrate-rich, and dietary nitrate can be converted to nitric oxide, a signaling molecule that relaxes blood vessels. A study published in the British Journal of Clinical Pharmacology found that foods high in dietary nitrates, like Swiss chard, have multiple vascular benefits, including reducing blood pressure, inhibiting platelet aggregation, and preserving or improving endothelial function.

4. Scientific Evidence by Area of Use

4.1 Blood Glucose Regulation and Diabetes

Swiss chard has traditionally been used as a folk treatment to reduce blood glucose levels. Several preclinical studies have examined this application. In one animal study, the chard extract had no effect on blood glucose and body weight in the normal group but reduced the blood glucose value in streptozotocin-induced hyperglycemic animals. In the diabetic group given chard extract, an increase in the number of B cells of Langerhans islets and in the secretory granules was noted; blood glucose reduction was maximal on the 42nd day, and it was concluded that the extract, when administered by gavage, may reduce blood glucose levels by regeneration of pancreatic B cells.

A separate study on chard extract's effects on cardiovascular tissues in streptozotocin-diabetic rats used streptozotocin at 65 mg/kg intraperitoneally to induce diabetes; chard extract at 2 g/kg was given for 28 days beginning on the 14th day of the study. In vitro studies have also shown the ethanol extract of wild Swiss chard leaves to exhibit good enzyme inhibitory effects on α-glucosidase and α-amylase activities, which are relevant to post-meal blood glucose control. Specifically, compounds such as vitexin have been reported to have superior antidiabetic effects compared to traditional medications in some experimental settings.

Evidence quality: All current evidence on anti-diabetic effects is from in vitro (cell/enzyme) studies and rodent models. No controlled human clinical trials on chard extract for diabetes management have been identified in the literature. The evidence is preliminary and cannot be extrapolated directly to humans.

4.2 Cardiovascular Health and Blood Pressure

Modern pharmacology shows that Beta vulgaris cicla extracts possess antihypertensive and hypoglycemic activity as well as excellent antioxidant activity. People whose diets are low in the minerals calcium, magnesium, and potassium are more likely to have high blood pressure; these minerals are thought to reduce blood pressure by releasing sodium out of the body and helping arteries dilate. One cooked cup can provide around one-third of an adult's magnesium needs and 20% of potassium.

Regarding lipid effects, the extract of chard plant leaves shows hepatoprotective effects in rats intoxicated by administration of acetaminophen and exhibits hypolipidemic activity in rats with high-fat-diet-induced hypercholesterolemia. A 2016 meta-analysis found evidence that regular intake of leafy greens leads to a significant (15.8%) reduced incidence of cardiovascular disease, though this finding applies to leafy greens broadly rather than to chard specifically. More research is warranted to understand the cardioprotective effects of Swiss chard in humans specifically.

Evidence quality: Mechanistic plausibility is supported by the mineral content and dietary nitrate evidence. Animal studies have shown lipid-lowering and blood-pressure-reducing effects, but no human RCTs specifically on Swiss chard extract for cardiovascular endpoints have been identified. Population-level observational data on leafy green consumption are supportive but not chard-specific.

4.3 Hepatoprotective (Liver-Protective) Effects

The significance of bioactive molecules from chard extracts has been addressed, and their antioxidant, anti-acetylcholinesterase, anti-diabetic, anti-inflammatory, antitumor, and hepatoprotective effects have been demonstrated in experimental work. A study by Istanbul University on diabetic rats found that chard extract had a liver-protective effect. The hepatoprotective activity in rats intoxicated with acetaminophen has also been documented and was attributed principally to the flavonoid fraction of the leaf extract.

Evidence quality: Evidence is limited to animal models and in vitro systems. No human clinical data specifically assessing chard's hepatoprotective properties have been identified.

4.4 Antioxidant Activity

A 2025 study evaluating total polyphenol content and antioxidant activity in Swiss chard found that leaves consistently exhibited higher levels of TPC and antioxidant activity than stems, with values reaching up to 9,634 mg GAE/kg DM and 15.9 mmol TE/kg DM, respectively. The ethanol extract of wild Swiss chard leaves has revealed significant antioxidant capacity in vitro. Swiss chard's many antioxidants include polyphenols, vitamin C, vitamin E, and carotenoid plant pigments such as beta-carotene; these nutrients help protect cells from free radical damage, and a diet high in these antioxidants may decrease the chances of developing certain chronic diseases.

Evidence quality: Antioxidant capacity is well-characterized analytically in vitro. Its translation to meaningful clinical antioxidant benefits in humans has not been established through dedicated clinical trials for chard specifically. It should be noted that in vitro antioxidant assays do not reliably predict outcomes in human physiology.

4.5 Antiproliferative and Anticancer Properties

Vitexin-2-O-xyloside, in combination with betaxanthins and betacyanins, exerts antiproliferative activity in breast, liver, colon, and bladder cancer cell lines, through the induction of both intrinsic and extrinsic apoptotic pathways. A significant body of evidence also points to the role of these phytochemicals in the downregulation of pro-survival genes, baculoviral inhibitor of apoptosis repeat-containing 5 and catenin beta-1, as well as the genes controlling angiogenesis, hypoxia-inducible factor 1A and vascular endothelial growth factor.

In one directly relevant cell study, the phenolic fraction (P2) from a Swiss chard extract and its single components were characterized for antioxidant capacity and antimitotic activity on MCF-7 human breast cancer cells; P2 inhibited MCF-7 cell proliferation (IC₅₀ value = 9 µg/ml) without inducing apoptosis, and showed no toxicity to human lymphocytes and only slight toxicity to macrophages. Vitexin-2′′O-rhamnoside strongly inhibited DNA synthesis in MCF-7 cells.

In cancer cells, vitexin flavonoids were able to induce intrinsic apoptosis, while betalains induced extrinsic apoptosis, and combinations of two or three molecules exhibited synergistic antioxidant, anti-inflammatory, and anticancer activity.

Swiss chard contains flavonoid antioxidants including quercetin, kaempferol, rutin, and vitexin; kaempferol is a powerful anti-inflammatory compound that may also have anticancer properties; vitexin, another flavonoid, may help prevent heart disease by lowering blood pressure, reducing inflammation, and blocking the formation of blood clots.

Evidence quality: All anticancer evidence comes from cell-line (in vitro) studies and, in some cases, animal models. There are no human clinical trials examining Swiss chard or its isolated constituents as cancer treatments or preventatives. This area remains at an early, experimental stage, and in-vitro cell findings cannot be considered evidence of clinical efficacy.

4.6 Bone Health

Vitamin K1 (phylloquinone), which is mostly found in plant sources, is abundant in Swiss chard; just 1 cup (175 grams) of cooked Swiss chard offers 477% of the DV for this nutrient. Vitamin K is required for blood clotting and various cellular functions and is essential for bone health; the body needs it to form osteocalcin, a protein involved in bone formation and maintenance. Vitamin K is essential for the synthesis of osteocalcin, a protein synthesized by osteoblasts that plays an important role in new bone formation; several studies have shown that low dietary intake of vitamin K is associated with low bone density and an increased risk of fractures.

Evidence quality: The relationship between vitamin K intake and bone health is supported by epidemiological and intervention studies on dietary vitamin K broadly (not chard specifically). Swiss chard is a documented source of vitamin K1, and regular dietary inclusion is consistent with meeting established vitamin K recommendations.

4.7 Eye Health

The carotenoids lutein and zeaxanthin in chard act as natural sunblock, filtering out harmful high-energy blue light waves and protecting the eye from oxidative damage; according to the American Optometric Association, diets rich in lutein and zeaxanthin are linked to a reduced risk of age-related macular degeneration (AMD) and cataracts, which are the leading causes of visual impairment in older adults, and just one cup of Swiss chard provides a substantial dose of these vision-protecting nutrients. According to studies carried out by the USDA Human Nutrition Research Center on Aging, carotenoids are able to protect the retina and cornea and defend against age-related disorders of the eyes, including macular degeneration, glaucoma, night blindness, and cataracts.

Evidence quality: The protective association between dietary lutein/zeaxanthin and age-related macular degeneration is one of the better-established areas in nutrition epidemiology, supported by numerous large cohort studies and review articles. The evidence implicates dietary carotenoid-rich vegetables broadly, with Swiss chard as one relevant source, rather than chard in isolation.

4.8 Anti-Inflammatory Activity

C-glycosyl flavones in chard extracts downregulate proinflammatory mediators (TNF-α, IL-1β, IL-6, IL-33, nitric oxide, and prostaglandin E₂) while promoting the anti-inflammatory cytokine IL-10. This has been documented primarily in cell-based and animal systems. No human RCTs specifically on chard extract for inflammatory outcomes have been identified.

5. Body Systems and Health Areas Associated with Chard

• Cardiovascular system: dietary nitrates promoting vasodilation; potassium and magnesium supporting blood pressure; flavonoids with anti-platelet and lipid-modifying effects (animal/in-vitro evidence).
• Metabolic/endocrine: flavonoid inhibition of α-glucosidase and α-amylase; alpha-lipoic acid supporting insulin sensitivity; pancreatic B-cell protective effects shown in animal models.
• Hepatic (liver): hepatoprotective effects against acetaminophen-induced toxicity demonstrated in rats; antioxidant protection of liver tissue.
• Skeletal: vitamin K1 supporting osteocalcin synthesis and bone mineral density based on broad dietary vitamin K literature.
• Ocular: lutein and zeaxanthin accumulating in the retina, associated epidemiologically with reduced AMD and cataract risk.
• Immune and cellular protection: antioxidant compounds (betalains, vitamin C, polyphenols) protecting against oxidative stress; C-glycosyl flavonoids with antiproliferative activity in cancer cell lines.
• Digestive: dietary fiber content supporting gut motility; historical use for digestive complaints.
• Neurological: preliminary animal evidence of chard extract protecting against brain oxidative damage induced by valproic acid.

6. Dosage Forms and Dosages Reported in Studies

Swiss chard is primarily consumed as a whole food vegetable. In pharmacological and traditional supplement research, various preparations and dosages have been explored:

• In a streptozotocin-diabetic rat study examining cardiovascular tissue, a chard extract dose of 2 g/kg body weight was administered for 28 days beginning on the 14th day after diabetes induction.
• In a rat study on valproic acid-induced brain damage, a chard extract dose of 100 mg/kg/day by gavage was used; aqueous chard leaf extract was given 1 hour before valproic acid administration for a period of 7 days.
• In the MCF-7 breast cancer cell line study, the phenolic fraction P2 inhibited MCF-7 cell proliferation with an IC₅₀ value of 9 µg/ml in vitro.
• As a food, just 1 cup (175 grams) of cooked Swiss chard offers 477% of the daily value for vitamin K.

No standardized therapeutic dosage for Swiss chard extract as a dietary supplement in humans has been established or validated in clinical trials to date.

7. Safety Considerations and Drug Interactions

Oxalate Content and Kidney Stones

Swiss chard has a very high oxalate content, one of the highest among edible vegetables; 100 grams of fresh leaves contain 480 mg of oxalates, of which about half is in soluble form. High oxalate intake has been linked to kidney stone formation, cardiovascular disease, and osteoporosis. Swiss chard contains antinutritive oxalates, which may increase urinary oxalate excretion and increase the risk of calcium oxalate stones. Like other leafy greens, Swiss chard is high in oxalates, which play a role in the formation of calcium oxalate kidney stones; to help prevent kidney stones, staying well hydrated, limiting sodium intake, and getting enough calcium are recommended. Swiss chard is one of the high-oxalate leafy greens, with reported oxalate levels reaching several hundred to over one thousand milligrams per 100 g fresh weight.

Trace element analysis has indicated the presence of lead and cadmium in all samples studied, with lead exceeding the permissible limit in the leaves of one sample, underscoring the importance of sourcing chard from controlled agricultural environments.

Interaction with Anticoagulant Therapy (Warfarin)

One of the key components in Swiss chard is vitamin K, which plays an essential role in blood clotting and bone health; while vitamin K is beneficial for most individuals, it can interact with blood-thinning medications like warfarin (Coumadin). Because Swiss chard is extremely rich in vitamin K1, large fluctuations in intake can interfere with vitamin K-sensitive anticoagulants like warfarin; clinical and patient education resources emphasize keeping vitamin K intake consistent, not eliminating it, so that warfarin doses can be accurately adjusted, as abruptly increasing or decreasing leafy green intake can change INR (a measure of blood clotting) and alter bleeding risk.

Pollen-Related Allergy Cross-Reactivity

If sensitive to grass pollen, individuals should be aware that inhaling vapor from boiling Swiss chard may trigger rhinoconjunctivitis. Though uncommon, allergies to Swiss chard have been reported.

Sodium Content

A cup of Swiss chard provides 44% of the daily allowance of vitamin A and 18% of the recommended amount of vitamin C; however, it already contains 103 mg of sodium per raw cup, which is 4.5% of the recommended daily allowance.

Heavy Metal Considerations

The need for environmental monitoring to ensure food safety is emphasized by researchers, as the observed variability in chemical composition highlights the influence of plant part, genotype, and environmental conditions; overall, Swiss chard represents a promising functional food, particularly when cultivated under controlled agroecological practices that minimize contaminant exposure.

References

• Mzoughi Z et al. (2019). Wild edible Swiss chard leaves (Beta vulgaris L. var. cicla): Nutritional, phytochemical composition and biological activities. Food Research International. PubMed PMID 30884696.
• Piovesana A et al. (2020). Bioactive compounds and nutritional composition of Swiss chard (Beta vulgaris L. var. cicla and flavescens): a systematic review. Critical Reviews in Food Science and Nutrition. PubMed PMID 32746613.
• Elhawary EA et al. (2016). Beta vulgaris subspecies cicla var. flavescens (Swiss chard): flavonoids, hepatoprotective and hypolipidemic activities. PubMed PMID 27209705.
• Ninfali P et al. (2007). Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla). PubMed PMID 16698256.
• Bolkent S et al. (2000). Effects of chard (Beta vulgaris L. var. cicla) extract on pancreatic B cells in streptozotocin-diabetic rats: a morphological and biochemical study. PubMed PMID 11025163.
• Sener G et al. (2002). Effects of chard (Beta vulgaris L. var. cicla) extract on oxidative injury in the aorta and heart of streptozotocin-diabetic rats. PubMed PMID 12511111.
• Ninfali P, Antonini E, Frati A, Scarpa ES. (2017). C-Glycosyl Flavonoids from Beta vulgaris Cicla and Betalains from Beta vulgaris rubra: Antioxidant, Anticancer and Antiinflammatory Activities—A Review. Phytotherapy Research, 31(6):871–884. PMID 28464411.
• Čeryová N et al. (2025). Nutritional Composition, Polyphenol Content, and Antioxidant Activity of Swiss Chard (Beta vulgaris L. subsp. cicla). Agrobiodiversity for Improving Nutrition, Health and Life Quality, 9(1).
• Encyclopaedia Britannica. Chard (Beta vulgaris). Britannica.com.
• Wikipedia. Chard. Wikipedia.org.
• Royal Horticultural Society. Fascinating facts: Chard. RHS.org.uk.
• Back Then History. The History of Chard (Swiss Chard). BackThenHistory.com.
• Medical News Today. Swiss chard: Possible health benefits, uses, and risks. MedicalNewsToday.com.
• Healthline. Swiss Chard: Nutrition, Health Benefits, and How to Cook It. Healthline.com.
• ScienceDirect Topics. Swiss Chard — an overview. ScienceDirect.com.
• VitaLibrary. Swiss chard nutrition profile, oxalate safety, and cooking tips. VitaLibrary.com.
• Cleveland Clinic. Swiss Chard: Benefits, Nutrients and How To Eat. Health.ClevelandClinic.org.
• USPTO. Hybrid Swiss chard variety 69-104 RZ. US Patent 10,015,949.
• UIC Heritage Garden. Swiss Chard (Beta vulgaris L. subsp. cicla). HertiageGarden.UIC.edu.
• Nutrition-and-You.com. Swiss chard (silverbeet) Nutrition facts and Health benefits.